Lijfering Willem M, Sprenger Herman G, Georg Rita R, van der Meulen Piet A, van der Meer Jan
Division of Haemostasis, Thrombosis and Rheology and Division of Infectious Diseases, Department of Internal Medicine, University Medical Center Groningen (UMCG), Groningen, The Netherlands.
Clin Chem. 2008 Jul;54(7):1226-33. doi: 10.1373/clinchem.2008.103614. Epub 2008 May 1.
HIV-infected patients are at increased risk of venous and arterial thrombosis. We hypothesized that acquired thrombophilic abnormalities that could predispose to thrombosis are most pronounced in patients in advanced stages of HIV infection.
We included 109 consecutive HIV-infected patients in the study and tested them twice for currently known thrombophilic abnormalities at an interval of at least 3 months (median, 3 months; range, 3-12 months). Detailed information was collected about the date of diagnosis of HIV infection, HIV treatment, and previous episodes of venous and arterial thrombosis.
After HIV infection was diagnosed, 16% of the patients experienced symptomatic thrombosis (venous, 10%; arterial, 6%). Repeated measurements established protein C deficiency in 9% of the patients, increased factor VIII concentrations in 41%, high fibrinogen concentrations in 22%, and free protein S deficiency in 60%. Median factor VIII concentrations were higher in patients with AIDS (CD4 cell counts <2 x 10(8)/L) than in patients with a non-AIDS-defining illness (2260 IU/L vs 1 490 IU/L; P < 0.001), whereas median free protein S concentrations were lower (450 IU/L vs 580 IU/L; P < 0.001). Developing AIDS was associated with increasing factor VIII concentrations and decreasing free protein S concentrations. Increasing factor VIII concentrations were correlated with increasing fibrinogen concentrations and decreasing free protein S concentrations.
Multiple acquired and persistent thrombophilic abnormalities are more frequently observed in HIV-infected patients than in the healthy population. The frequencies of these thrombophilic abnormalities increase with the progression to AIDS. These findings may contribute to the high prevalence of venous and arterial thrombosis in HIV-infected patients.
HIV感染患者发生静脉和动脉血栓形成的风险增加。我们推测,易导致血栓形成的获得性血栓形成倾向异常在HIV感染晚期患者中最为明显。
我们纳入了109例连续的HIV感染患者进行研究,并至少间隔3个月(中位数为3个月;范围为3 - 12个月)对他们进行两次目前已知的血栓形成倾向异常检测。收集了有关HIV感染诊断日期、HIV治疗以及既往静脉和动脉血栓形成发作的详细信息。
HIV感染诊断后,16%的患者出现症状性血栓形成(静脉血栓形成占10%;动脉血栓形成占6%)。重复检测发现9%的患者存在蛋白C缺乏,41%的患者因子VIII浓度升高,22%的患者纤维蛋白原浓度升高,60%的患者游离蛋白S缺乏。艾滋病患者(CD4细胞计数<2×10⁸/L)的因子VIII浓度中位数高于无艾滋病定义疾病的患者(2260 IU/L对1490 IU/L;P<0.001),而游离蛋白S浓度中位数较低(450 IU/L对580 IU/L;P<0.001)。进展为艾滋病与因子VIII浓度升高和游离蛋白S浓度降低相关。因子VIII浓度升高与纤维蛋白原浓度升高和游离蛋白S浓度降低相关。
与健康人群相比,HIV感染患者更频繁地出现多种获得性和持续性血栓形成倾向异常。这些血栓形成倾向异常的频率随着进展至艾滋病而增加。这些发现可能有助于解释HIV感染患者中静脉和动脉血栓形成的高患病率。